Elite Pharmaceuticals Inc (ELTP)

[rrr2003]

There is no mention of a 15 cent share price or reverse split (to uplist to NASDAQ) anywhere in the Q2 2022 CC (November 16/2021):

"Amphetamine XR and Amphetamine IR, these are products that are in a very competitive market frankly. And they have done very well for us. We have done very well to date with our partner, Lannett. We have discussed NASDAQ on money calls before and there is a question on that on this call. So I will say a couple thoughts about uplifting for NASDAQ. A key goal for Elite is uplisting to NASDAQ. When the time is right, there are specific requirements that Elite must meet to qualify for the uplisting. We are working diligently to achieve them. We will continue to monitor our growth and income generation and we'll update you on uplisting when the time is right.

To wrap up, Elite is executing on its growth plans, working on new product approvals and capitalizing on its commercial product line. Our sales and distribution partners are performing well. We look forward to another profitable quarter."

Can you find the quote where Nasrat said the share price must be .15 - .25 before the reverse split takes place.

I think it's in the following CC but don't have access to it. (might be in another CC)

https://seekingalpha.com/article/4470089-elite-pharmaceuticals-inc-eltp-ceo-nasrat-hakim-on-q2-2022-results-earnings-call-transcript

Please find the exact quote and post it here.